High levels of patient satisfaction in joint uro-oncology clinics to assist patient choice in early prostate cancer and muscle-invasive bladder cancer

High levels of patient satisfaction in joint uro-oncology clinics to assist patient choice in early prostate cancer and muscle-invasive bladder cancer

Pokaż inne wersje (1)

Multidisciplinary clinics are useful where there is patient choice, but patients are often seen sequentially, rather than synchronously in the same room. The National Institute for Health and Care Excellence (NICE) guidelines for bladder and prostate cancer [1,2] do not currently recommend using syn...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Kiltie, A, Southby, R, LeMonnier, K, Binnee, J, Niederer, J, Kartsonaki, C, Camilleri, P, Sabharwal, A, Brewster, S, Crew, J, Hamdy, F
Format:	Journal article
Wydane:	Elsevier 2018

Podobne zapisy

High levels of patient satisfaction in joint uro-oncology clinics to assist patient choice in early prostate cancer and muscle-invasive bladder cancer
od: Kiltie, A, i wsp.
Wydane: (2018)

Automated uro-oncology data collection: the Cancer Research Uro-Oncology Database.
od: Charlesworth, P, i wsp.
Wydane: (2010)

Molecular oncology of prostate cancer /
od: Ross, Jeffrey S. (Jeffrey Stuart), 1945-, i wsp.
Wydane: (2007)

Targeting chemotherapy to advanced bladder cancer patients most likely to benefit.
od: Catto, J, i wsp.
Wydane: (2010)

Common predisposition alleles for moderately common cancers: bladder cancer.
od: Kiltie, A
Wydane: (2010)

Recommendations for follow-up of muscle-invasive bladder cancer patients: A consensus by the international bladder cancer network
od: Zuiverloon, TCM, i wsp.
Wydane: (2018)

Gemcitabine as a Chemoradiosensitiser in Bladder Cancer
od: Kerr, M, i wsp.
Wydane: (2012)

MicroRNA in prostate, bladder, and kidney cancer: A systematic review
od: Catto, J, i wsp.
Wydane: (2011)

MicroRNA in prostate, bladder, and kidney cancer: a systematic review.
od: Catto, J, i wsp.
Wydane: (2011)

Prostate cancer early detection. Clinical practice guidelines in oncology.
od: Kawachi, M, i wsp.
Wydane: (2007)

Prostate cancer early detection: Clinical practice guidelines in oncology™
od: Kawachi, M, i wsp.
Wydane: (2010)

Computed tomography urography for diagnosing bladder cancer.
od: Turney, B, i wsp.
Wydane: (2006)

Utility of bladder-sparing therapy vs radical cystectomy for muscle-invasive bladder cancer
od: Efstathiou, J, i wsp.
Wydane: (2018)

High-throughput DNA sequencing identifies novel CtIP (RBBP8) variants in muscle-invasive bladder cancer patients
od: Jevons, S, i wsp.
Wydane: (2015)

Molecular epidemiology of DNA repair genes in bladder cancer.
od: Kiltie, A
Wydane: (2009)

The oncologic role of local treatment in primary metastatic prostate cancer.
od: Ghadjar, P, i wsp.
Wydane: (2014)

Patient-reported outcomes following treatment for localized prostate cancer: Helping decision making for patients and their physicians.
od: Hamdy, F, i wsp.
Wydane: (2017)

Comparing gene promoter methylation frequencies in urine from patients with bladder cancer with urine from non-cancerous young and elderly control patients
od: Yates, DR, i wsp.
Wydane: (2005)

NCCN clinical practice guidelines in oncology: prostate cancer early detection.
od: Kawachi, M, i wsp.
Wydane: (2010)

Contemporary patterns of multidisciplinary care in patients with muscle-invasive bladder cancer
od: Harshman, LC, i wsp.
Wydane: (2017)

In vitro functional effects of XPC gene rare variants from bladder cancer patients.
od: Qiao, B, i wsp.
Wydane: (2011)

Predictive Biomarkers for Gemcitabine as a Chemoradiosensitizer in Bladder Cancer
od: Kerr, M, i wsp.
Wydane: (2012)

Natural language processing in urology: automated extraction of clinical information from histopathology reports of uro-oncology procedures
od: Huang, Honghong, i wsp.
Wydane: (2023)

Artificial intelligence for the prediction bladder cancer
od: Abbod, M, i wsp.
Wydane: (2004)

Serum osteoprotegerin (OPG) levels and disease progression in prostate cancer patients
od: Eaton, C, i wsp.
Wydane: (2004)

Does the introduction of prostate multiparametric MRI into active surveillance of localised prostate cancer improve patient re-classification?
od: Bryant, R, i wsp.
Wydane: (2018)

Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls.
od: Yates, DR, i wsp.
Wydane: (2006)

Orient expression: solving the mystery of Asian prostate cancer?
od: Lamb, A, i wsp.
Wydane: (2017)

Using gene polymorphisms to assess bladder cancer risk: progress and challenges.
od: Kiltie, A
Wydane: (2012)

Using gene polymorphisms to assess bladder cancer risk: Progress and challenges
od: Kiltie, A
Wydane: (2012)

Bladder cancer in women
od: Nicholson, B, i wsp.
Wydane: (2014)

Bladder cancer in women.
od: Nicholson, B, i wsp.
Wydane: (2014)

Comprehensive analysis of 22 XPC polymorphisms and bladder cancer risk.
od: Sak, S, i wsp.
Wydane: (2006)

Functional assays to determine the significance of two common XPC 3'UTR variants found in bladder cancer patients.
od: Qiao, B, i wsp.
Wydane: (2011)

Staging in prostate cancer.
od: Wilkinson, B, i wsp.
Wydane: (2002)

Artificial intelligence and bladder cancer arrays.
od: Wild, P, i wsp.
Wydane: (2007)

DNA repair gene XRCC1 polymorphisms and bladder cancer risk
od: Sak, S, i wsp.
Wydane: (2007)

Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study.
od: Rehman, I, i wsp.
Wydane: (2004)

Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer.
od: Stern, M, i wsp.
Wydane: (2009)

Prostate cancer: screening approaches.
od: Donovan, J, i wsp.
Wydane: (2005)